Cargando...
Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2
Rationale: An imbalance between protein synthesis and degradation is one of the mechanisms of cardiac hypertrophy. Increased transcription in cardiomyocytes can lead to excessive protein synthesis and cardiac hypertrophy. Maf1 is an RNA polymerase III (RNA pol III) inhibitor that plays a pivotal rol...
Guardado en:
| Publicado en: | Theranostics |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Ivyspring International Publisher
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831308/ https://ncbi.nlm.nih.gov/pubmed/31695767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.33006 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|